ADENOVIRUS GENOME CONSTRUCTION WITH LAC OPERON COMPONENT FOR COVID-19 VACCINE CANDIDATE PRODUCTION

The development of adenovirus based COVID-19 vaccine used as delivery vector for SARS-CoV-2 virus spike gene is carried out to handle pandemic. Lac System is a transcriptional regulatory system that can be used to inhibit Spike protein expression in host cells for optimal adenovirus production...

Full description

Saved in:
Bibliographic Details
Main Author: Arifa Arbuati, Arrie
Format: Theses
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/76601
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
Description
Summary:The development of adenovirus based COVID-19 vaccine used as delivery vector for SARS-CoV-2 virus spike gene is carried out to handle pandemic. Lac System is a transcriptional regulatory system that can be used to inhibit Spike protein expression in host cells for optimal adenovirus production. This study aims to construct an adenovirus genome with the lac operon as a regulatory component of Lac System for the production of COVID-19 vaccine candidate. Synthetic gene was designed having components of the lac operon, SV40 intron, and multiple cloning sites (MCS). Restriction enzyme sites were mapped on the synthetic gene design for pShuttleCMV-lacO-Spike and pShuttleCMV-lacO-Intron-Spike plasmids construction using restriction and ligation methods. Homologous recombination between pShuttleCMV-lacO-Spike and pAdEasy adenovirus genome was successfully performed in Escherichia coli BJ5183. The presence of hexon gene, spike gene, and lac operon on pAdEasy-lacO-Spike was identified using PCR with specific primers. The results of PCR analysis showed experimental size of 146 bp for hexon gene (theoretical size 168 bp), 3,872 bp for spike gene (theoretical size 3,848 bp), and 2,201 bp for lac operon (theoretical size 2,070 bp), proving the existence of the three genes on pAdEasy-lacO-Spike. Initial adenovirus production was performed by pAdEasy-lacO-Spike transfection in AD293 cells, using pAdEasy-Spike and pAdyEasy-lacZ as controls. Adenovirus production success was confirmed using PCR with specific primers. The results of PCR analysis showed experimental size of 148 bp for the hexon gene (theoretical size 168 bp) and 183 bp for the spike gene (theoretical size 183 bp). Adenovirus titers produced from transfection were 6.12 × 105 IFU/mL for AdV-lacO-Spike, 7.65 × 105 IFU/mL for AdV-Spike, and 1.07 × 106 IFU/mL for AdV-lacZ. Adenovirus titers of AdV-lacO-Spike was comparable to AdV-Spike indicated initial production success of AdV-lacO-Spike, with pAdEasy-lacO-Spike adenovirus production capability comparable to pAdEasy-Spike.